The DOI matches its Crossref record; 302 of the 302 references it cites were found in a registry or an index.
Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder
Open accessAbstract
Parkinson's disease (PD) is the second most common movement disorder. The characteristic motor impairments - bradykinesia, rigidity, and resting tremor - result from degenerative loss of midbrain dopamine (DA) neurons in the substantia nigra, and are responsive to symptomatic treatment with dopaminergic medications and functional neurosurgery. PD is also the second most common neurodegenerative disorder. Viewed from this perspective, PD is a disorder of multiple functional systems, not simply the motor system, and of multiple neurotransmitter systems, not merely that of DA. The characteristic pathology - intraneuronal Lewy body inclusions and reduced numbers of surviving neurons - is similar in each of the targeted neuron groups, suggesting a common neurodegenerative process. Pathological and experimental studies indicate that oxidative stress, proteolytic stress, and inflammation figure prominently in the pathogenesis of PD. Yet, whether any of these mechanisms plays a causal role in human PD is unknown, because to date we have no proven neuroprotective therapies that slow or reverse disease progression in patients with PD. We are beginning to understand the pathophysiology of motor dysfunction in PD, but its etiopathogenesis as a neurodegenerative disorder remains poorly understood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 2×
“45 Notable among these are the noradrenergic neurons of the locus ceruleus (LC) 46,47 and the serotonergic nuclei of the median raphe (nMR).”
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564
Functional architecture of basal ganglia circuits: neural substrates of parallel processing
Alexander, G. E., & Crutcher, M. D. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90107-l · Cited by 4,131
Self-citationPrimate models of movement disorders of basal ganglia origin
DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Frequency Dependence of Signal Power and Spatial Reach of the Local Field Potential
Leski, S., Lindén, H., Tetzlaff, T., Pettersen, K. H., & Einevoll, G. T. (2013) · PubMed · doi:10.18154/rwth-conv-084442 · Cited by 3,639
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Alexander, G. E., Crutcher, M. D., & DeLong, M. R. (1990) · PubMed · Cited by 2,680
Self-citationGetting formal with dopamine and reward
Schultz, W. (2002) · Neuron · doi:10.1016/s0896-6273(02)00967-4 · Cited by 2,574
Berridge, C. W., & Waterhouse, B. D. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00143-7 · Cited by 2,529 · cited 2×
“49,69,70 Of course, depletion of nBM neurons is also seen—characteristically so—in Alzheimer’s disease (AD), which is by far the most common neurodegenerative disorder.”
Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex
Cardinal, R. N., Parkinson, J. A., Hall, J., & Everitt, B. J. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(02)00007-6 · Cited by 2,129
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
(1991) · Progress in Brain Research · doi:10.1016/s0079-6123(08)62678-3 · Cited by 1,961
Basal ganglia and cerebellar loops: motor and cognitive circuits
Middleton, F. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00040-5 · Cited by 1,940
Reversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus
Bergman, H., Wichmann, T., & DeLong, M. R. (1990) · Science · doi:10.1126/science.2402638 · Cited by 1,907
Haber, S. N., Fudge, J. L., & McFarland, N. R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-06-02369.2000 · Cited by 1,610
Neuronal Coding of Prediction Errors
Schultz, W., & Dickinson, A. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.473 · Cited by 1,427
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism
Bergman, H., Wichmann, T., Karmon, B., & DeLong, M. R. (1994) · Journal of Neurophysiology · doi:10.1152/jn.1994.72.2.507 · Cited by 1,365
Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein
Lotharius, J., & Brundin, P. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn983 · Cited by 1,283
Striatal interneurones: chemical, physiological and morphological characterization
Kawaguchi, Y., Wilson, C. J., Augood, S. J., & Emson, P. C. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)98374-8 · Cited by 1,198
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M. T., Michel, P. P., Marquez, J., Prigent, A., Ruberg, M., Hirsch, É. C., & Agid, Y. (1997) · PubMed · Cited by 1,188
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoy‐Agid, F., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360305 · Cited by 1,161
Schenck, C. H., Bundlie, S. R., & Mahowald, M. W. (1996) · Neurology · doi:10.1212/wnl.46.2.388 · Cited by 1,083
Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey
Selemon, L., & Goldman-Rakic, P. (1985) · The Journal of Neuroscience · doi:10.1523/jneurosci.05-03-00776.1985 · Cited by 1,073
Mechanism of Toxicity in Rotenone Models of Parkinson's Disease
Sherer, T. B., Betarbet, R., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno-Yagi, A., & Greenamyre, J. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10756.2003 · Cited by 1,072
Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,002
A Clinicopathologic Study of 100 Cases of Parkinson's Disease
Hughes, A. J., Daniel, S. E., Blankson, S., & Lees, A. J. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540020018011 · Cited by 956
Synaptic organisation of the basal ganglia
BOLAM, J. P., HANLEY, J. J., BOOTH, P. A. C., & BEVAN, M. D. (2000) · Journal of Anatomy · doi:10.1046/j.1469-7580.2000.19640527.x · Cited by 948
Olson, E. J., Boeve, B. F., & Silber, M. H. (2000) · Brain · doi:10.1093/brain/123.2.331 · Cited by 895
Parkinson Disease in Twins: An Etiologic Study
Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 867
The Neurobiology of Slow Synaptic Transmission
Greengard, P. (2001) · Science · doi:10.1126/science.294.5544.1024 · Cited by 867
Alam, Z. I., Jenner, A., Daniel, S. E., Lees, A. J., Cairns, N., Marsden, C. D., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031196.x · Cited by 845 · cited 1×
“96,150,151 152-154 Why this occurs is uncertain, 153,155 but the excess nigral iron is likely to enhance local oxidative stress.”
The pedunculopontine nucleus and Parkinson's disease
Pahapill, P. A. (2000) · Brain · doi:10.1093/brain/123.9.1767 · Cited by 831
Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791 · cited 1×
“103,169,170 Most of the inflammatory cells at these sites are activated microglia, although lesser numbers of reactive astrocytes are seen as well.”
Where Does Parkinson Disease Pathology Begin in the Brain?
Del Tredici, K., Rüb, U., de Vos, R. A. I., Bohl, J. R. E., & Braak, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.5.413 · Cited by 773
DARPP-32: An Integrator of Neurotransmission
Svenningsson, P., Nishi, A., Fisone, G., Girault, J.-A., Nairn, A. C., & Greengard, P. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121415 · Cited by 720
Sherer, T. B., Kim, J.-H., Betarbet, R., & Greenamyre, J. T. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8072 · Cited by 708
Activity Patterns in a Model for the Subthalamopallidal Network of the Basal Ganglia
Terman, D., Rubin, J. E., Yew, A. C., & Wilson, C. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02963.2002 · Cited by 686
Pathology of Parkinson’s disease: Changes other than the nigrostriatal pathway
Jellinger, K. A. (1991) · Molecular and Chemical Neuropathology · doi:10.1007/bf03159935 · Cited by 684
Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson’s disease
Levy, R., Ashby, P., Hutchison, W. D., Lang, A. E., Lozano, A. M., & Dostrovsky, J. O. (2002) · Brain · doi:10.1093/brain/awf128 · Cited by 683
Basal Ganglia Output and Cognition: Evidence from Anatomical, Behavioral, and Clinical Studies
Middleton, F. A., & Strick, P. L. (2000) · Brain and Cognition · doi:10.1006/brcg.1999.1099 · Cited by 661
Nini, A., Feingold, A., Slovin, H., & Bergman, H. (1995) · Journal of Neurophysiology · doi:10.1152/jn.1995.74.4.1800 · Cited by 648
Move to the rhythm: oscillations in the subthalamic nucleus–external globus pallidus network
Bevan, M. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02235-x · Cited by 638
Zhang, J., Perry, G., Smith, M. A., Robertson, D., Olson, S. J., Graham, D. G., & Montine, T. J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65396-5 · Cited by 636
Excitatory Cortical Inputs to Pallidal Neurons Via the Subthalamic Nucleus in the Monkey
Nambu, A., Tokuno, H., Hamada, I., Kita, H., Imanishi, M., Akazawa, T., Ikeuchi, Y., & Hasegawa, N. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.84.1.289 · Cited by 603
Multiple Output Channels in the Basal Ganglia
Hoover, J. E., & Strick, P. L. (1993) · Science · doi:10.1126/science.7679223 · Cited by 590
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y., & Hirsch, E. C. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90684-x · Cited by 590
Gronseth, G. S., & Barohn, R. J. (2000) · Neurology · doi:10.1212/wnl.55.1.7 · Cited by 576
Le Moine, C., & Bloch, B. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903550308 · Cited by 575
Coincident but Distinct Messages of Midbrain Dopamine and Striatal Tonically Active Neurons
Morris, G., Arkadir, D., Nevet, A., Vaadia, E., & Bergman, H. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.012 · Cited by 574
Raz, A., Vaadia, E., & Bergman, H. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08559.2000 · Cited by 574
Gibb, W. R., & Lees, A. J. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.5.388 · Cited by 574
Huguenard, Jr., & Prince, D. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-10-03804.1992 · Cited by 562
Baron, M. S., Vitek, J. L., Green, J., Kaneoke, Y., Hashimoto, T., Turner, R. S., Woodard, J. L., Delong, M. R., Bakay, R. A. E., Cole, S. A., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410400305 · Cited by 558
The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease
Paulus, W., & Jellinger, K. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00006 · Cited by 554
Alam, Z. I., Daniel, S. E., Lees, A. J., Marsden, D. C., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031326.x · Cited by 547
Targeting programmed cell death in neurodegenerative diseases
Vila, M., & Przedborski, S. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1100 · Cited by 546
Diffusion tensor fiber tracking shows distinct corticostriatal circuits in humans
Lehéricy, S., Ducros, M., Van De Moortele, P., Francois, C., Thivard, L., Poupon, C., Swindale, N., Ugurbil, K., & Kim, D. (2004) · Annals of Neurology · doi:10.1002/ana.20030 · Cited by 542
Protein Nitration in Parkinsonʼs Disease
Good, P. F., Hsu, A., Werner, P., Perl, D. P., & Olanow, C. W. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199804000-00006 · Cited by 540
Lewis, S. J. G., Dove, A., Robbins, T. W., Barker, R. A., & Owen, A. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06351.2003 · Cited by 532
Acute and Long-Term Effects of Subthalamic Nucleus Stimulation in Parkinson's Disease
Benabid, A. L., Pollak, P., Gross, C., Hoffmann, D., Benazzouz, A., Gao, D. M., Laurent, A., Gentil, M., & Perret, J. (1994) · Stereotactic and Functional Neurosurgery · doi:10.1159/000098600 · Cited by 532
E PIDEMIOLOGY OF N EURODEGENERATION
Mayeux, R. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.043002.094919 · Cited by 515
Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990
Bower, J. H., Maraganore, D. M., McDonnell, S. K., & Rocca, W. A. (1999) · Neurology · doi:10.1212/wnl.52.6.1214 · Cited by 511
Mutations in NR4A2 associated with familial Parkinson disease
Le, W.-D., Xu, P., Jankovic, J., Jiang, H., Appel, S. H., Smith, R. G., & Vassilatis, D. K. (2003) · Nature Genetics · doi:10.1038/ng1066 · Cited by 487
Hersch, S., Ciliax, B., Gutekunst, C., Rees, H., Heilman, C., Yung, K., Bolam, J., Ince, E., Yi, H., & Levey, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-07-05222.1995 · Cited by 483
Pathological changes in the nucleus of meynert in Alzheimer's and Parkinson's diseases
Candy, J. M., Perry, R. H., Perry, E. K., Irving, D., Blessed, G., Fairbairn, A. F., & Tomlinson, B. E. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90045-x · Cited by 459
Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease
Harding, A. J., Stimson, E., Henderson, J. M., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf251 · Cited by 443
Synucleins in synaptic plasticity and neurodegenerative disorders
Clayton, D. F., & George, J. M. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991001)58:1<120::aid-jnr12>3.0.co;2-e · Cited by 442
Acetylcholine-mediated modulation of striatal function
Calabresi, P., Centonze, D., Gubellini, P., Pisani, A., & Bernardi, G. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01501-5 · Cited by 440
Wichmann, T., Bergman, H., & DeLong, M. R. (1994) · Journal of Neurophysiology · doi:10.1152/jn.1994.72.2.521 · Cited by 427
Zgaljardic, D. J., Borod, J. C., Foldi, N. S., & Mattis, P. (2003) · Cognitive and Behavioral Neurology · doi:10.1097/00146965-200312000-00001 · Cited by 421
Hunot, S., Dugas, N., Faucheux, B., Hartmann, A., Tardieu, M., Debré, P., Agid, Y., Dugas, B., & Hirsch, E. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-09-03440.1999 · Cited by 408
Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease
Halliday, G. M., Li, Y. W., Blumbergs, P. C., Joh, T. H., Cotton, R. G. H., Howe, P. R. C., Blessing, W. W., & Geffen, L. B. (1990) · Annals of Neurology · doi:10.1002/ana.410270405 · Cited by 408
Neuropathology of Autonomic Nervous System in Parkinson's Disease
Wakabayashi, K., & Takahashi, H. (1997) · European Neurology · doi:10.1159/000113469 · Cited by 407
Genetic and environmental factors in the cause of Parkinson's disease
Warner, T. T., & Schapira, A. H. V. (2003) · Annals of Neurology · doi:10.1002/ana.10487 · Cited by 399
Neuroinflammatory processes in Parkinson's disease
Hunot, S., & Hirsch, E. C. (2003) · Annals of Neurology · doi:10.1002/ana.10481 · Cited by 398
Olfactory dysfunction in Parkinson's disease.
Hawkes, C. H., Shephard, B. C., & Daniel, S. E. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.5.436 · Cited by 396
The pedunculopontine nucleus in Parkinson's disease
Zweig, R. M., Jankel, W. R., Hedreen, J. C., Mayeux, R., & Price, D. L. (1989) · Annals of Neurology · doi:10.1002/ana.410260106 · Cited by 386
Calabresi, P., Gubellini, P., Centonze, D., Picconi, B., Bernardi, G., Chergui, K., Svenningsson, P., Fienberg, A. A., & Greengard, P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08443.2000 · Cited by 380
Tofaris, G. K., Razzaq, A., Ghetti, B., Lilley, K. S., & Spillantini, M. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308041200 · Cited by 361
Gastrointestinal dysfunction in Parkinson's disease: Frequency and pathophysiology
Edwards, L. L., Quigley, E. M. M., & Pfeiffer, R. F. (1992) · Neurology · doi:10.1212/wnl.42.4.726 · Cited by 359
Gainetdinov, R. R., Fumagalli, F., Jones, S. R., & Caron, M. G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031322.x · Cited by 353
Parthasarathy, H., Schall, J., & Graybiel, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-11-04468.1992 · Cited by 353
Prefrontostriatal connections in relation to cortical architectonic organization in rhesus monkeys
Yeterian, E. H., & Pandya, D. N. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903120105 · Cited by 351
Specification of catecholaminergic and serotonergic neurons
Goridis, C., & Rohrer, H. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn871 · Cited by 350
[ 123 I]β-CIT SPECT imaging assessment of the rate of Parkinson’s disease progression
Marek, K., Innis, R., van Dyck, C., Fussell, B., Early, M., Eberly, S., Oakes, D., & Seibyl, J. (2001) · Neurology · doi:10.1212/wnl.57.11.2089 · Cited by 347
Flaherty, A. W., & Graybiel, A. M. (1991) · Journal of Neurophysiology · doi:10.1152/jn.1991.66.4.1249 · Cited by 343
Mink, J. W., & Thach, W. T. (1991) · Journal of Neurophysiology · doi:10.1152/jn.1991.65.2.330 · Cited by 341
Mechanisms Underlying Spontaneous Oscillation and Rhythmic Firing in Rat Subthalamic Neurons
Bevan, M. D., & Wilson, C. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-17-07617.1999 · Cited by 341
Neural Bases of Set-Shifting Deficits in Parkinson's Disease
Monchi, O., Petrides, M., Doyon, J., Postuma, R. B., Worsley, K., & Dagher, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4860-03.2004 · Cited by 341
Behavioural assessment of mice lacking D1A dopamine receptors
Smith, D. R., Striplin, C. D., Geller, A. M., Mailman, R. B., Drago, J., Lawler, C. P., & Gallagher, M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00608-8 · Cited by 332
Novel anti-inflammatory therapy for Parkinson's disease
Gao, H.-M., Liu, B., Zhang, W., & Hong, J.-S. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00176-7 · Cited by 324
Anatomy of the dopamine system in the basal ganglia
Smith, Y., & Kieval, J. Z. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00023-9 · Cited by 323
Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease
Castellani, R., Smith, M. A., Richey, G. L., & Perry, G. (1996) · Brain Research · doi:10.1016/0006-8993(96)00729-9 · Cited by 315
Tompkins, M. M., Basgall, E. J., ZAMRINI, E. Y., & Hill, W. D. (1997) · Europe PMC (PubMed Central) · Cited by 314
Huisman, E., Uylings, H. B. M., & Hoogland, P. V. (2004) · Movement Disorders · doi:10.1002/mds.10713 · Cited by 313
An inflammatory review of Parkinson's disease
Orr, C. F., Rowe, D. B., & Halliday, G. M. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00127-2 · Cited by 309
Contributions of the Pedunculopontine Region to Normal and Altered REM Sleep
Rye, D. B. (1997) · Sleep · doi:10.1093/sleep/20.9.757 · Cited by 307
Berendse, H. W., Booij, J., Francot, C. M. J. E., Bergmans, P. L. M., Hijman, R., Stoof, J. C., & Wolters, E. C. (2001) · Annals of Neurology · doi:10.1002/ana.1049 · Cited by 299
Trojanowski, J. Q., Goedert, M., Iwatsubo, T., & Lee, V. M.-Y. (1998) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400432 · Cited by 297
Amygdala pathology in Parkinson's disease
Braak, H., Braak, E., Yilmazer, D., de Vos, R. A. I., Jansen, E. N. H., Bohl, J., & Jellinger, K. (1994) · Acta Neuropathologica · doi:10.1007/bf00296485 · Cited by 295
Shink, E., Bevan, M. D., Bolam, J. P., & Smith, Y. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00022-x · Cited by 295
Neuroprotection in Parkinson Disease: Mysteries, Myths, and Misconceptions
Schapira, A. H. V., & Olanow, C. W. (2004) · JAMA · doi:10.1001/jama.291.3.358 · Cited by 288
Decreased dopamine in the retinas of patients with Parkinson's disease.
Harnois, C., & Paolo, T. D. (1990) · PubMed · Cited by 286
Ilinsky, I. A., & Kultas‐Ilinsky, K. (1987) · Journal of Comparative Neurology · doi:10.1002/cne.902620303 · Cited by 286
Kita, H., & Kitai, S. T. (1991) · Brain Research · doi:10.1016/0006-8993(91)91466-e · Cited by 284
Excitotoxicity and nitric oxide in parkinson's disease pathogenesis
Beal, M. F. (1998) · Annals of Neurology · doi:10.1002/ana.410440716 · Cited by 283
Gerfen, C., Keefe, K., & Gauda, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-12-08167.1995 · Cited by 283
Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H., & Nagatsu, T. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050028 · Cited by 282
Shtilerman, M. D., Ding, T. T., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi0120906 · Cited by 281
Thiruchelvam, M., McCormack, A., Richfield, E. K., Baggs, R. B., Tank, A. W., Di Monte, D. A., & Cory‐Slechta, D. A. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02781.x · Cited by 280
Le, W.-D., Rowe, D., Xie, W., Ortiz, I., He, Y., & Appel, S. H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08447.2001 · Cited by 275
Dementia in idiopathic Parkinson's disease: A neuropathological study of 32 cases
Gaspar, P., & Gray, F. (1984) · Acta Neuropathologica · doi:10.1007/bf00695605 · Cited by 275
Boraud, T., Bezard, E., Bioulac, B., & Gross, C. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)12943-8 · Cited by 270
Lotharius, J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2395 · Cited by 269
Zecca, L., Zucca, F. A., Wilms, H., & Sulzer, D. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.009 · Cited by 264
Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease
Dev, K. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00140-0 · Cited by 263
Subthalamotomy in parkinsonian monkeys Behavioural and biochemical analysis
Guridi, J., Herrero, M. T., Luquin, M. R., Guillén, J., Ruberg, M., Laguna, J., Vila, M., Javoy-Agid, F., Agid, Y., Hirsch, E., et al. (1996) · Brain · doi:10.1093/brain/119.5.1717 · Cited by 263
UCHL1 is a Parkinson's disease susceptibility gene
Maraganore, D. M., Lesnick, T. G., Elbaz, A., Chartier‐Harlin, M., Gasser, T., Krüger, R., Hattori, N., Mellick, G. D., Quattrone, A., Satoh, J., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20017 · Cited by 262
Raz, A., Feingold, A., Zelanskaya, V., Vaadia, E., & Bergman, H. (1996) · Journal of Neurophysiology · doi:10.1152/jn.1996.76.3.2083 · Cited by 261
The rotenone model of Parkinson's disease: genes, environment and mitochondria
Greenamyre, J. T., Betarbet, R., & Sherer, T. B. (2003) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(03)00023-3 · Cited by 259
Pathophysiology of Parkinson's Disease: The MPTP Primate Model of the Human Disorder
WICHMANN, T., & DeLONG, M. R. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07477.x · Cited by 255
Lavoie, B., & Parent, A. (1994) · Journal of Comparative Neurology · doi:10.1002/cne.903440203 · Cited by 254
Höglinger, G. U., Carrard, G., Michel, P. P., Medja, F., Lombès, A., Ruberg, M., Friguet, B., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01952.x · Cited by 253
Dopaminergic Neurons Intrinsic to the Primate Striatum
Betarbet, R., Turner., R., Chockkan, V., DeLong, M. R., Allers, K. A., Walters, J., Levey, A. I., & Greenamyre, J. T. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-17-06761.1997 · Cited by 251
MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects.
Langston, J. W., Langston, E. B., & Irwin, I. (1984) · PubMed · Cited by 249
Axonal branching pattern of neurons of the subthalamic nucleus in primates
Sato, F., Parent, M., Lévesque, M., & Parent, A. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20000814)424:1<142::aid-cne10>3.0.co;2-8 · Cited by 249
Mitochondrial dysfunction in Parkinson's disease
Greenamyre, J. T., MacKenzie, G., Peng, T.-I., & Stephans, S. E. (1999) · Biochemical Society Symposia · doi:10.1042/bss0660085 · Cited by 248
Organization of striatopallidal, striatonigral, and nigrostriatal projections in the macaque
Hedreen, J. C., & Delong, M. R. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903040406 · Cited by 244
Environmental Factors in Parkinson’s Disease
Di Monte, D. A., Lavasani, M., & Manning-Bog, A. B. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00099-2 · Cited by 240
Neuroprotective Strategies in Parkinson???s Disease: An Update on Progress
Mandel, S., Gr??nblatt, E., Riederer, P., Gerlach, M., Levites, Y., & Youdim, M. B. H. (2003) · CNS Drugs · doi:10.2165/00023210-200317100-00004 · Cited by 237
Abnormalities in color vision and contrast sensitivity in Parkinson's disease
Price, M. J., Feldman, R. G., Adelberg, D., & Kayne, H. (1992) · Neurology · doi:10.1212/wnl.42.4.887 · Cited by 236
Dopamine D2 Receptor–Mediated Presynaptic Inhibition of Olfactory Nerve Terminals
Ennis, M., Zhou, F.-M., Ciombor, K. J., Aroniadou-Anderjaska, V., Hayar, A., Borrelli, E., Zimmer, L. A., Margolis, F., & Shipley, M. T. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.6.2986 · Cited by 234
Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease
Gaspar, P., Duyckaerts, C., Alvarez, C., Javoy‐Agid, F., & Berger, B. (1991) · Annals of Neurology · doi:10.1002/ana.410300308 · Cited by 231
Inase, M., Tokuno, H., Nambu, A., Akazawa, T., & Takada, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01531-0 · Cited by 230
Chemin, J., Monteil, A., Perez‐Reyes, E., Bourinet, E., Nargeot, J., & Lory, P. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.013269 · Cited by 230
Fall, P., Saleh, A., Fredrickson, M., Olsson, J., & Granérus, A. (2003) · Movement Disorders · doi:10.1002/mds.10537 · Cited by 228
Recent advances in the genetics and pathogenesis of Parkinson disease
Mouradian, M. M. (2002) · Neurology · doi:10.1212/wnl.58.2.179 · Cited by 228
Descarries, L., Watkins, K. C., Garcia, S., Bosler, O., & Doucet, G. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961111)375:2<167::aid-cne1>3.0.co;2-0 · Cited by 221
Courbon, F., Brefel‐Courbon, C., Thalamas, C., Alibelli, M. J., Berry, I., Montastruc, J., Rascol, O., & Senard, J. (2003) · Movement Disorders · doi:10.1002/mds.10461 · Cited by 221
Druschky, A., Hilz, M. J., Platsch, G., Radespiel-Tröger, M., Druschky, K., Kuwert, T., & Neundörfer, B. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00279-3 · Cited by 221
Stefurak, T., Mikulis, D., Mayberg, H., Lang, A. E., Hevenor, S., Pahapill, P., Saint‐Cyr, J., & Lozano, A. (2003) · Movement Disorders · doi:10.1002/mds.10593 · Cited by 215
Parkin mutations and susceptibility alleles in late‐onset Parkinson's disease
Oliveira, S. A., Scott, W. K., Martin, E. R., Nance, M. A., Watts, R. L., Hubble, J. P., Koller, W. C., Pahwa, R., Stern, M. B., Hiner, B. C., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10524 · Cited by 214
Takada, M., Tokuno, H., Nambu, A., & Inase, M. (1998) · Experimental Brain Research · doi:10.1007/s002210050384 · Cited by 211
Goldberg, J. A., Rokni, U., Boraud, T., Vaadia, E., & Bergman, H. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4848-03.2004 · Cited by 211
Benabid, A. L., Koudsié, A., Benazzouz, A., Vercueil, L., Fraix, V., Chabardes, S., LeBas, J. F., & Pollak, P. (2001) · Journal of Neurology · doi:10.1007/pl00007825 · Cited by 210
Treatment of Parkinson's disease: levodopa as the first choice
Katzenschlager, R., & Lees, A. J. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1204-4 · Cited by 209
Sakai, S. T., Inase, M., & Tanji, J. (1996) · The Journal of Comparative Neurology · Cited by 209
Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson’s disease
McNaught, K. S. P., & Olanow, C. W. (2003) · Annals of Neurology · doi:10.1002/ana.10512 · Cited by 203
Cavada, C., & Goldman-Rakic, P. S. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90037-o · Cited by 203
Parkinson's disease mortality and pesticide exposure in California 1984–1994
Ritz, B., & Yu, F. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.2.323 · Cited by 203
Nandi, D. (2002) · Brain · doi:10.1093/brain/awf259 · Cited by 202
Corticostriatal connections of extrastriate visual areas in rhesus monkeys
Yeterian, E. H., & Pandya, D. N. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903520309 · Cited by 202
Lewy body cortical involvement may not always predict dementia in Parkinson's disease
Colosimo, C. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.852 · Cited by 200
Frontal-striatal circuit functions: Context, sequence, and consequence
SAINT-CYR, J. A. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703910125 · Cited by 200
Unilateral subthalamotomy in the treatment of Parkinson's disease
Patel, N. K., Heywood, P., O'Sullivan, K., McCarter, R., Love, S., & Gill, S. S. (2003) · Brain · doi:10.1093/brain/awg111 · Cited by 193
Rochet, J.-C., Outeiro, T. F., Conway, K. A., Ding, T. T., Volles, M. J., Lashuel, H. A., Bieganski, R. M., Lindquist, S. L., & Lansbury, P. T. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:1-2:023 · Cited by 191
Soares, J., Kliem, M. A., Betarbet, R., Greenamyre, J. T., Yamamoto, B., & Wichmann, T. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0836-04.2004 · Cited by 190
Bevan, M. D., Magill, P. J., Hallworth, N. E., Bolam, J. P., & Wilson, C. J. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00582.2001 · Cited by 185
Gaspar, P., Stepniewska, I., & Kaas, J. H. (1992) · Journal of Comparative Neurology · doi:10.1002/cne.903250102 · Cited by 182
Survival Study of Parkinson Disease in Olmsted County, Minnesota
Elbaz, A., Bower, J. H., Peterson, B. J., Maraganore, D. M., McDonnell, S. K., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.1.91 · Cited by 179
Coordinated expression of muscarinic receptor messenger RNAs in striatal medium spiny neurons
Yan, Z., Flores-Hernandez, J., & Surmeier, D. J. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00039-2 · Cited by 179
Double, K. L., Rowe, D. B., Hayes, M., Chan, D. K. Y., Blackie, J., Corbett, A., Joffe, R., Fung, V. S., Morris, J., & Halliday, G. M. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.545 · Cited by 177
Peroxynitrite and Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease
Ebadi, M., & Sharma, S. K. (2003) · Antioxidants & Redox Signaling · doi:10.1089/152308603322110896 · Cited by 176
McDonald, A. J. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960212)365:3<367::aid-cne3>3.0.co;2-2 · Cited by 175
Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991.
Schulte, P. A., Burnett, C. A., Boeniger, M. F., & Johnson, J. G. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.9.1281 · Cited by 175
Parkinson's disease, pesticides and mitochondrial dysfunction
Jenner, P. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01789-6 · Cited by 173
The Subthalamic Nucleus and Tremor in Parkinson's Disease
Rodriguez, M. C., Guridi, O. J., Alvarez, L., Mewes, K., Macias, R., Vitek, J., DeLong, M. R., & Obeso, J. A. (2008) · Movement Disorders · doi:10.1002/mds.870131320 · Cited by 171
Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease.
Kumar, R., Lang, A. E., Rodriguez-Oroz, M., Lozano, A. M., Limousin, P. D., Pollak, P., Benabid, A., Guridi, J., Ramos, E., Linden, C. V. D., et al. (2000) · PubMed · Cited by 170
L-DOPA: From a biologically inactive amino acid to a successful therapeutic agent
Hornykiewicz, O. (2002) · Amino Acids · doi:10.1007/s00726-001-0111-9 · Cited by 168
Temporal Difference Model Reproduces Anticipatory Neural Activity
Suri, R. E., & Schultz, W. (2001) · Neural Computation · doi:10.1162/089976601300014376 · Cited by 166
Lynd‐Balta, E., & Haber, S. N. (1994) · Journal of Comparative Neurology · doi:10.1002/cne.903450407 · Cited by 165
Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen
Ouimet, C. C., Langley-Gullion, K. C., & Greengard, P. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00724-0 · Cited by 165
Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases
Gu, M., Owen, A. D., Toffa, S. E. K., Cooper, J. M., Dexter, D. T., Jenner, P., Marsden, C. D., & Schapira, A. H. V. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00095-1 · Cited by 164
Ubiquinone (Coenzyme Q10) and Mitochondria in Oxidative Stress of Parkinson’s Disease
Ebadi, M., Govitrapong, P., Sharma, S., Muralikrishnan, D., Shavali, S., Pellett, L. J., Schafer, R., Albano, C. B., & Eken, J. (2001) · Neurosignals · doi:10.1159/000046889 · Cited by 162
Samuel, M., Caputo, E., Brooks, D., Schrag, A., Scaravilli, T., Branston, N., Rothwell, J., Marsden, C., Thomas, D. G. T., Lees, A., et al. (1998) · Brain : a journal of neurology · doi:10.1093/brain/121.1.59 · Cited by 160
Kojima, J., Yamaji, Y., Matsumura, M., Nambu, A., Inase, M., Tokuno, H., Takada, M., & Imai, H. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00254-1 · Cited by 159
Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease
Barzilai, A., & Melamed, E. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00020-0 · Cited by 158
Cortical Lewy body dementia: clinical features and classification.
Gibb, W. R. G., Luthert, P. J., Janota, I., & Lantos, P. L. (1989) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.2.185 · Cited by 158
Parkinson's disease: piecing together a genetic jigsaw
Dekker, M. C. J., Bonifati, V., & van Duijn, C. M. (2003) · Brain · doi:10.1093/brain/awg172 · Cited by 158
Autonomic dysfunction in Parkinson's disease
Micieli, G., Tosi, P., Marcheselli, S., & Cavallini, A. (2003) · Neurological Sciences · doi:10.1007/s100720300035 · Cited by 157
Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease
Brown, R. G., Limousin, P. D., Brown, P., Jahanshahi, M., Pollak, P., Benabid, A., Rodríguez-Oroz, M. C., Obeso, J. A., & Rothwell, J. C. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199904)45:4<473::aid-ana9>3.0.co;2-v · Cited by 157
Recent developments in the pathology of Parkinson’s disease
Jellinger, K. A. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_33 · Cited by 157
Sidib�, M., & Smith, Y. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960212)365:3<445::aid-cne8>3.0.co;2-4 · Cited by 155
Bonifati, V., Oostra, B. A., & Heutink, P. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0512-1 · Cited by 155
Guridi, J., & Obeso, J. (2001) · Brain : a journal of neurology · doi:10.1093/brain/124.1.5 · Cited by 155
Nishi, A., Bibb, J. A., Matsuyama, S., Hamada, M., Higashi, H., Nairn, A. C., & Greengard, P. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00876.x · Cited by 154
Mechanistic Approaches to Parkinson's Disease Pathogenesis
Betarbet, R. S., Sherer, T., Monte, D. A. D., & Greenamyre, J. T. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00468.x · Cited by 153
Orimo, S. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.6.776 · Cited by 150
Gwinn, K. A. (2002) · Movement Disorders · doi:10.1002/mds.10173 · Cited by 149
Nakano, K., Hasegawa, Y., Tokushige, A., Nakagawa, S., Kayahara, T., & Mizuno, N. (1990) · Brain Research · doi:10.1016/0006-8993(90)90339-d · Cited by 144
The role of primate putamen neurons in the association of sensory stimuli with movement
Kimura, M. (1986) · Neuroscience Research · doi:10.1016/0168-0102(86)90035-0 · Cited by 142
Selective Agenesis of Mesencephalic Dopaminergic Neurons in Nurr1-Deficient Mice
Le, W., Conneely, O. M., Zou, L., He, Y., Cárdenas, O. S., Jankovic, J. J., Mosier, D. R., & Appel, S. H. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7191 · Cited by 141
Compartmental origins of the striatopallidal projection in the primate
Giménez‐Amaya, J. M., & Graybiel, A. M. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90306-o · Cited by 141
Output architecture of the primate putamen
Flaherty, A. W., & Graybiel, A. M. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-08-03222.1993 · Cited by 138
Cited by
Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683
Maiti, P., Manna, J., & Dunbar, G. L. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0099-z · Cited by 525
Manoharan, S., Guillemin, G. J., Abiramasundari, R. S., Essa, M. M., Akbar, M., & Akbar, M. D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8590578 · Cited by 523
Picca, A., Calvani, R., Coelho-Junior, H. J., Landi, F., Bernabei, R., & Marzetti, E. (2020) · Antioxidants · doi:10.3390/antiox9080647 · Cited by 437
Role of NAD+ in regulating cellular and metabolic signaling pathways
Amjad, S., Nisar, S., Bhat, A. A., Shah, A. R., Frenneaux, M. P., Fakhro, K., Haris, M., Reddy, R., Patay, Z., Baur, J., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101195 · Cited by 384
Metadata
- Authors
- Alexander, G. E.
- Venue
- Dialogues in Clinical Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2004-09-30
- Volume
- 6
- Issue
- 3
- Pages
- 259-280
- ISSN
- 1294-8322 (ISSN-L)
- 1958-5969
- OpenAlex
- W4213459747
- Cited by
- 523
- References
- 302
- FWCI
- 0.21
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.